What Eli Lilly Investors Can Learn from the Slow Launch of a Rival Drug
Club holding company Eli Lilly hopes to win approval for its Alzheimer's treatment in the coming weeks, but investors looking…
biogen inc
Biogen (BIIB) earnings in the fourth quarter of 2023
biogen on Tuesday reported fourth-quarter revenue and profit that fell from a year ago as it booked charges related to…
Biogen abandons Alzheimer's drug Aduhelm to focus on Leqembi, others
Biogen headquarters in Cambridge, Massachusetts, on October 24, 2023. vanessa leroy | Bloomberg | fake images biogen on Wednesday said…
Citi and others are bullish on biotech, medtech and more
2023 was not a good year for the healthcare sector, but some investors expect it to return this year, highlighting…